These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32633149)

  • 1. Recent advances in the development of asenapine formulations.
    Suresh A; Narayan R; Nayak UY
    Expert Opin Drug Deliv; 2020 Oct; 17(10):1377-1393. PubMed ID: 32633149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Drug Delivery Approach via Self-Microemulsifying Drug Delivery System for Enhancing Oral Bioavailability of Asenapine Maleate: Optimization, Characterization, Cell Uptake, and In Vivo Pharmacokinetic Studies.
    Patel MH; Mundada VP; Sawant KK
    AAPS PharmSciTech; 2019 Jan; 20(2):44. PubMed ID: 30617712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-transfersomal formulations for transdermal delivery of asenapine maleate: in vitro and in vivo performance evaluations.
    Shreya AB; Managuli RS; Menon J; Kondapalli L; Hegde AR; Avadhani K; Shetty PK; Amirthalingam M; Kalthur G; Mutalik S
    J Liposome Res; 2016 Sep; 26(3):221-32. PubMed ID: 26621370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-emulsifying drug delivery system for enhanced solubility of asenapine maleate: design, characterization, in vitro, ex vivo and in vivo appraisal.
    Avasarala H; Dinakaran SK; Kakaraparthy R; Jayanti VR
    Drug Dev Ind Pharm; 2019 Apr; 45(4):548-559. PubMed ID: 30623677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of long acting invasomal nanovesicles for improved transdermal permeation and bioavailability of asenapine maleate for the chronic treatment of schizophrenia.
    El-Tokhy FS; Abdel-Mottaleb MMA; El-Ghany EA; Geneidi AS
    Int J Pharm; 2021 Oct; 608():121080. PubMed ID: 34506923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential Formulation of Second Generation Antipsychotic Asenapine as Inclusion Complex with Sulphobutylether-βCD (Captisol): In vitro and In vivo Evaluation.
    Kulkarni JA; Avachat AM; Avachat CM; Pradhan R; Suryawanshi TS; Khan EM; Martis EAF; Coutinho EC; Padhye S
    Curr Drug Deliv; 2018; 15(4):520-531. PubMed ID: 29165075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic and pharmacokinetic investigation of cyclodextrin-mediated asenapine maleate in situ nasal gel for improved bioavailability.
    Kulkarni JA; Avachat AM
    Drug Dev Ind Pharm; 2017 Feb; 43(2):234-245. PubMed ID: 27625143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of Asenapine Maleate in Pharmaceutical and Biological Matrices: A Critical Review of Analytical Techniques over the Past Decade.
    Kotak V; Tanna N; Patel M; Patel R
    Crit Rev Anal Chem; 2022; 52(8):1755-1771. PubMed ID: 34061690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asenapine maleate in situ forming biodegradable implant: an approach to enhance bioavailability.
    Avachat AM; Kapure SS
    Int J Pharm; 2014 Dec; 477(1-2):64-72. PubMed ID: 25305379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate.
    Yasir M; Gaur PK; Puri D; Shehkar P; Kumar SS
    Curr Drug Deliv; 2018; 15(6):818-828. PubMed ID: 28545354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: In vitro and in vivo studies for brain targeting.
    Kumbhar SA; Kokare CR; Shrivastava B; Gorain B; Choudhury H
    Int J Pharm; 2020 Aug; 586():119499. PubMed ID: 32505580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2009 Dec; 63(12):1762-84. PubMed ID: 19840150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asenapine: a new antipsychotic option.
    Henry JM; Fuller MA
    J Pharm Pract; 2011 Oct; 24(5):447-51. PubMed ID: 22156709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal Delivery of Antipsychotics: Rationale and Current Status.
    Abruzzo A; Cerchiara T; Luppi B; Bigucci F
    CNS Drugs; 2019 Sep; 33(9):849-865. PubMed ID: 31493244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asenapine review, part II: clinical efficacy, safety and tolerability.
    Citrome L
    Expert Opin Drug Saf; 2014 Jun; 13(6):803-30. PubMed ID: 24793161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced intestinal absorption of asenapine maleate by fabricating solid lipid nanoparticles using TPGS: elucidation of transport mechanism, permeability across Caco-2 cell line and in vivo pharmacokinetic studies.
    Patel M; Mundada V; Sawant K
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):144-153. PubMed ID: 30669881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nose-to-brain delivery of antipsychotics using nanotechnology: a review.
    Tan MSA; Parekh HS; Pandey P; Siskind DJ; Falconer JR
    Expert Opin Drug Deliv; 2020 Jun; 17(6):839-853. PubMed ID: 32343186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice.
    Fagiolini A; Forgione RN; Morana B; Maccari M; Goracci A; Bossini L; Pellegrini F; Cuomo A; Casamassima F
    Expert Opin Pharmacother; 2013 Mar; 14(4):489-504. PubMed ID: 23356509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In brief: An asenapine patch (Secuado) for schizophrenia.
    Med Lett Drugs Ther; 2021 Jan; 63(1615):7-8. PubMed ID: 33647000
    [No Abstract]   [Full Text] [Related]  

  • 20. Microneedles as an alternative technology for transdermal drug delivery systems: a patent review.
    Queiroz MLB; Shanmugam S; Santos LNS; Campos CA; Santos AM; Batista MS; Araújo AAS; Serafini MR
    Expert Opin Ther Pat; 2020 Jun; 30(6):433-452. PubMed ID: 32164470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.